Cirrus D20: DigiTOF technology

Enabling prescription of targeted therapeutics / antibiotics for common infectious diseases

To help turn back AMR, the Cirrus D20 has been developed, allowing identification of microorganisms direct from patient samples without the need to culture

Empowering first and second line health care professionals to prescribe targeted antibiotics for common infectious diseases

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics

Microorganisms:
  • Bacteria

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Validation
  • Market entry

Organization:
  • Company
  • Government

Partnering:
  • License

Having expertise in the area of manufacturing, medical applications, business development

BiosparQ is a high-tech start-up company (15 fte) located at the Bio Science parc in Leiden

Other: expertise in the area of manufacturing, medical applications, business developme


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!